SaloOP. SLE-like deposition of immunoglobulins in the skin in rosacea: a clinical and immunofluorescent study.Ann Clin Res1970; 2: 28–31.
37.
SeijiM, OtakiN.Haber's syndrome: familial rosacea-like dermatitis with keratotic plaques and pitted scars.Arch Dematol1971; 103: 452–5.
38.
RowellNR, SummerscalesJE. Urinary excretion of 5-hydroxyindoleacetic acid in rosacea.J Invest Dermatol1961; 36: 405–6.
39.
WilkinJK, De WittS.Treatment of rosacea: topical clindamycine versus oral tetracycline.Int J Dermatol1993; 32: 65–7.
40.
EsterlyNB, FureyNL, FlanaganLE. The effect of antimicrobial agents on leukocyte Chemotaxis.J Invest Dermatol1978; 70: 51–5.
41.
SchmadelLK, McEvoyGK. Topical metronidazole: a new therapy for rosacea.Clin Pharm1990; 9: 94–101.
42.
DöringHF, IlgnerM.Rosaceatherapie mit Bifonazol-Creme—Praktische Erfahrungen über 2 Jahre.Z Hautkr1986; 61: 490–4.
43.
BlomI, HornmarkAM. Topical treatment with sulphur 10 per cent for rosacea.Acta Derm Venereol (Stockh)1984; 64: 358–9.
44.
KligmanAM. Topical tretinoin for rosacea: a preliminary report.J Dermatol Treat1993; 4: 71–3.
45.
PlewigG, Braun-FalcoO, KlövekornW, LuderschmidtC.Isotretinoin zur örtlichen Behandlung von Akne und Rosazea sowie tierexperimentelle Untersuchungen mit Isotretinoin und Arotinoid.Hautarzt1986; 37: 138–41.
46.
CarmichaelAJ, MarksR, GraupeKA, ZaumseilRP. Topical azelaic acid in the treatment of rosacea.J Dermatol Treat1993; 4(Suppl. 1): 19–22.
47.
MarksR, DawberRPR. Skin surface biopsy: an improved technique for the examination of the horny layer.Br J Dermatol1971; 84: 117–23.
48.
SneddonIB. A clinical trial of tetracycline in rosacea.Br J Dermatol1966; 78: 649–52.
49.
KnightA, VickersCFH. A follow-up of tetracycline-treated rosacea with special reference to rosacea keratitis.Br J Dermatol1975; 93: 577–80.
50.
MarsdenJR, ShusterS, NeugebauerM.Response of rosacea to isotretinoin.Clin Exp Dermatol1984; 9: 484–8.
51.
SchmidtJB, GebhardW, RaffM, SponaJ.13-cis-retinoic acid in rosacea. Clinical and laboratory findings.Acta Derm Venereol (Stockh)1984; 64: 15–21.
52.
TurjanmaaK, ReunalaT.Isotretinoin treatment of rosacea.Acta Derm Venereol (Stockh)1987; 67: 89–91.
53.
AizawaH, NiimuraM.Oral spironolactone therapy in male patients with rosacea.J Dermatol1992; 19: 293–7.
54.
CunliffeWJ, DodmanB, BinnerJG. Clonidine and facial flushing in rosacea.BMJ1977; I: 105.
55.
WilkinJK. Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions.Arch Dermatol1983; 119: 211–14.
56.
SaihanEM, BurtonJL. A double-blind trial of metronidazole versus Oxytetracycline for rosacea.Br J Dermatol1980; 102: 443–5.
57.
SobyeP.Aetiology and pathogenesis of rosacea.Acta Derm Venereol (Stockh)1950; 30: 137–40.
58.
PollaLL, TanOT, GardenJM, ParrishJA. Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia.Dermatologica1987; 171: 11–7.
59.
LloydKM. Surgical correction of rhinophyma.Arch Dermatol1990; 126: 721–3.
60.
RödderO, PlewigG.Rhinophyma and rosacea: combined treatment with isotretinoin and dermabrasion. In: MarksR, PlewigG, eds. Acne and Related Disorders.London: Dunitz,1989: 335—8.